Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
25
|
pubmed:dateCreated |
1977-12-29
|
pubmed:abstractText |
The prognostic features of the disease are summed up. The leading symptom of the disease is the dyspnoe followed by a dry hacking cough, loss of weight and fever. Clinically we find rales, cyanosis clubbing and signs of right heart insufficiency. Lung function data point to a decreased vital capacity and diffusing capacity; residual volume and functional residual capacity are about normal. Corticosteroid monotherapy is not an efficient treatment. The combination of prednisolon + azathioprine improves vital capacity but not working capacity. Prednisolone and d-penicillamine improve all parameters including working capacity. This can be enhanced by still adding azathioprine or cyclophosphamide to prednisolone and d-penicillamine.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0015-8178
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2157-61
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:914141-Azathioprine,
pubmed-meshheading:914141-Drug Therapy, Combination,
pubmed-meshheading:914141-Female,
pubmed-meshheading:914141-Humans,
pubmed-meshheading:914141-Life Expectancy,
pubmed-meshheading:914141-Lung Compliance,
pubmed-meshheading:914141-Male,
pubmed-meshheading:914141-Partial Pressure,
pubmed-meshheading:914141-Penicillamine,
pubmed-meshheading:914141-Prednisolone,
pubmed-meshheading:914141-Pulmonary Fibrosis,
pubmed-meshheading:914141-Vital Capacity
|
pubmed:year |
1977
|
pubmed:articleTitle |
[Idiopathic fibrosing alveolitis].
|
pubmed:publicationType |
Journal Article,
English Abstract
|